PAR paradigm biopharmaceuticals limited..

Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS, page-3

  1. 4,906 Posts.
    lightbulb Created with Sketch. 7636
    More good news...

    "PPS administered subcutaneously at Day 0 at 3mg/kg resulted in a statistically
    significant reduction in inflammatory cell infiltrates in the lungs at 8 days post infection"



    https://hotcopper.com.au/data/attachments/3680/3680151-9bbb4dc93bef58c529d9798da22b69fe.jpg
    Last edited by Mozzarc: 13/10/21
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
0.020(5.00%)
Mkt cap ! $166.9M
Open High Low Value Volume
40.0¢ 42.5¢ 39.5¢ $239.2K 576.9K

Buyers (Bids)

No. Vol. Price($)
3 8734 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 52500 3
View Market Depth
Last trade - 16.10pm 22/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.